Better understanding of the ways in which diverse sarbecoviruses have achieved compatibility with human ACE2 may help identify molecular barriers initially posed by ACE2 sequence differences that can be circumvented through RBD sequence adaptations from prior infection in various hosts. This evidence concerns the gene ACE2 and infection.